Cited 0 time in
miR-1226-5p is involved in radioresistance of colorectal cancer by activating M2 macrophages through suppressing IRF1
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Choi, Jae Yeon | - |
| dc.contributor.author | Seok, Hyun Jeong | - |
| dc.contributor.author | Lee, Dong Hyeon | - |
| dc.contributor.author | Kwon, Junhye | - |
| dc.contributor.author | Shin, Ui Sup | - |
| dc.contributor.author | Shin, Incheol | - |
| dc.contributor.author | Bae, In Hwa | - |
| dc.date.accessioned | 2024-11-28T19:00:42Z | - |
| dc.date.available | 2024-11-28T19:00:42Z | - |
| dc.date.issued | 2024-10 | - |
| dc.identifier.issn | 1479-5876 | - |
| dc.identifier.issn | 1479-5876 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/198041 | - |
| dc.description.abstract | Background: Although the representative treatment for colorectal cancer (CRC) is radiotherapy, cancer cells survive due to inherent radioresistance or resistance acquired after radiation treatment, accelerating tumor malignancy and causing local recurrence and metastasis. However, the detailed mechanisms of malignancy induced after radiotherapy are not well understood. To develop more effective and improved radiotherapy and diagnostic methods, it is necessary to clearly identify the mechanisms of radioresistance and discover related biomarkers. Methods: To analyze the expression pattern of miRNAs in radioresistant CRC, sequence analysis was performed in radioresistant HCT116 cells using Gene Expression Omnibus, and then miR-1226-5p, which had the highest expression in resistant cells compared to parental cells, was selected. To confirm the effect of miR-1226-5 on tumorigenicity, Western blot, qRT-PCR, transwell migration, and invasion assays were performed to confirm the expression of EMT factors, cell mobility and invasiveness. Additionally, the tumorigenic ability of miR-1226-5p was confirmed in organoids derived from colorectal cancer patients. In CRC cells, IRF1, a target gene of miR-1226-5p, and circSLC43A1, which acts as a sponge for miR-1226-5p, were discovered and the mechanism was analyzed by confirming the tumorigenic phenotype. To analyze the effect of tumor-derived miR-1226-5p on macrophages, the expression of M2 marker in co-cultured cells and CRC patient tissues were confirmed by qRT-PCR and immunohistochemical (IHC) staining analyses. Results: This study found that overexpressed miR-1226-5p in radioresistant CRC dramatically promoted epithelial-mesenchymal transition (EMT), migration, invasion, and tumor growth by suppressing the expression of its target gene, IRF1. Additionally, we discovered circSLC43A1, a factor that acts as a sponge for miR-1226-5p and suppresses its expression, and verified that EMT, migration, invasion, and tumor growth are suppressed by circSLC43A1 in radioresistant CRC cells. Resistant CRC cells-derived miR-1226-5p was transferred to macrophages and contributed to tumorigenicity by inducing M2 polarization and secretion of TGF-beta. Conclusions: This study showed that the circSLC43A1/miR-1226-5p/IRF1 axis is involved in radioresistance and cancer aggressiveness in CRC. It was suggested that the discovered signaling factors could be used as potential biomarkers for diagnosis and treatment of radioresistant CRC. | - |
| dc.format.extent | 18 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | BioMed Central | - |
| dc.title | miR-1226-5p is involved in radioresistance of colorectal cancer by activating M2 macrophages through suppressing IRF1 | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1186/s12967-024-05797-1 | - |
| dc.identifier.scopusid | 2-s2.0-85208130437 | - |
| dc.identifier.wosid | 001344795100003 | - |
| dc.identifier.bibliographicCitation | Journal of Translational Medicine, v.22, no.1, pp 1 - 18 | - |
| dc.citation.title | Journal of Translational Medicine | - |
| dc.citation.volume | 22 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 18 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Research & Experimental Medicine | - |
| dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
| dc.subject.keywordPlus | CELL | - |
| dc.subject.keywordPlus | ZEB1 | - |
| dc.subject.keywordPlus | EMT | - |
| dc.subject.keywordPlus | POLARIZATION | - |
| dc.subject.keywordPlus | DISCOVERY | - |
| dc.subject.keywordAuthor | Radioresistance of colorectal cancer | - |
| dc.subject.keywordAuthor | miR-1226-5p | - |
| dc.subject.keywordAuthor | IRF1 | - |
| dc.subject.keywordAuthor | M2 macrophage | - |
| dc.subject.keywordAuthor | Tumor malignancy | - |
| dc.subject.keywordAuthor | TGF-beta | - |
| dc.identifier.url | https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-024-05797-1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
